Articles From: IntelliCell BioSciences Announces Positive Final Ruling Against Ironridge Global IV, LTD., and TCA Global Credit Master Fund, LP to Interface Declares Regular Quarterly Dividend


NEW YORK , May 7, 2014 /PRNewswire/ -- IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has received a final positive ruling in its case against Ironridge Global IV, LTD.
Sign-up for IntelliCell BioSciences Announces Positive Final Ruling Against Ironridge Global IV, LTD., and TCA Global Credit Master Fund, LP investment picks
NEW YORK , May 13, 2014 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, announced today that Merril Hoge , former star NFL player and an on-air analyst for ESPN, has joined its Board of Advisors.
Sign-up for IntelliCell BioSciences announces That Merril Hoge has joined Its Board of Advisors investment picks
NEW YORK , April 29, 2014 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous Stromal Vascular Cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it supplied its Stromal Vascular Fraction Cells, manufactured using its patented ultrasonic technology, for the restoration of cardiac function at the University of Arizona College of Medicine, Tucson in collaboration with Dr.
Sign-up for IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey investment picks
2014/5/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112884&ProfileId=051205&sourceType=1 MIAMI, FL --
Sign-up for Intelligent Living Inc. (ILIV) Appoints Mark B. Lucky as Chief Financial Officer investment picks
2014/5/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117056&ProfileId=051205&sourceType=1 RENO, NV --
Sign-up for Interactive Health Network Acquires BIOTEL, a Managed Service Provider for the Cannabis Industry investment picks
2014/5/15
http://media.marketwire.com/attachments/201405/75345_ihnlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115978&ProfileId=051205&sourceType=1 RENO, NV --
Sign-up for Interactive Health Network Announces Cancellation of 1.25 Billion Shares of Common Stock investment picks
2014/5/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114258&ProfileId=051205&sourceType=1 RENO, NV --
Sign-up for Interactive Health Network Announces Interview of Cesar D. Vazquez investment picks
2014/5/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112398&ProfileId=051205&sourceType=1 RENO, NV --
Sign-up for Interactive Health Network Shareholder Update investment picks
2014/5/22
RENO, Nev.
Sign-up for Interactive Health Network To Present At The Third Annual Marcum MicroCap Conference investment picks
NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced the pricing of its previously announced underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $320.00 per share.
Sign-up for Intercept Pharmaceuticals Announces Pricing of Public Offering investment picks
NEW YORK, May 7, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), today reported financial results for the first quarter of 2014 and provided other general business updates.
Sign-up for Intercept Pharmaceuticals Reports First Quarter 2014 Financial Results investment picks
NEW YORK, May 6, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced new OBADIAH trial results showing potential clinical benefits of obeticholic acid (OCA) for patients with bile acid diarrhea.
Sign-up for Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week investment picks
NEW YORK, May 1, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced that it will report first quarter 2014 financial results after the NASDAQ Market closes on Wednesday, May 7, 2014.
Sign-up for Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences investment picks
2014/5/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1118216&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for INTERCLOUD 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against InterCloud Systems, Inc. - ICLD investment picks
SHREWSBURY, N.J., May 13, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems Inc. (Nasdaq:ICLD) ("InterCloud" or the "Company"), a single source provider of IT solutions through cloud platforms and professional services, will hold a conference call to discuss its financial results for the third quarter ended September 30, 2013.
Sign-up for InterCloud Announces Conference Call to Discuss First Quarter Financial Results investment picks
SHREWSBURY, N.J., April 11, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) , a single-source provider of end-to end IT and next generation network solutions to the service provider and corporate enterprise markets through cloud platforms and professional services, announced today that it was awarded two new major design contracts for small cell deployment.
Sign-up for InterCloud Contracts for Small Cell Network Deployment investment picks
SHREWSBURY, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) (the "Company" or "InterCloud"), filed a Registration Statement on Form S-1 today in order to comply with its obligations under those certain 12% convertible debentures dated December 13, 2013 (the "Debentures"). The Debentures as part of a $11.6 Million offering closed in December 2013, bear interest at the rate of 12% per annum, and mature on June 13, 2015.
Sign-up for InterCloud Files Resale Registration Statement in Connection With December 2013 Debenture investment picks
SHREWSBURY, N.J., April 29, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems Inc. (Nasdaq:ICLD) , a single source provider of IT solutions through cloud platforms and professional services, announced today that it signed a two year cloud-services agreement with digital forensics and cyber security company Ambient Data.
Sign-up for InterCloud Partners With Ambient Data for Cloud Services investment picks
NEW ORLEANS, May 5, 2014 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Sign-up for INTERCLOUD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against InterCloud Systems, Inc. -- ICLD investment picks
Revenue Increased 25% Year-Over-Year to $14.1 Million; Gross Profit Increased 33% to $3.9 Million Net Income $6.7 Million SHREWSBURY, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (Nasdaq:ICLD) , a single source provider of end-to-end IT technology and next-generation network solutions to the service provider and corporate enterprise markets through professional services and cloud platforms, today reported financial results for the first quarter ended March 31, 2014.
Sign-up for InterCloud Systems Reports First Quarter 2014 Results investment picks
Full-Year 2013 Revenue Increased 201% to $51.4 Million Full-Year 2013 Adjusted Pro-Forma EBITDA Increased to $6.9 Million Balance Sheet Improved SHREWSBURY, N.J., April 8, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (Nasdaq:ICLD) , a single source provider of end-to-end IT technology and telecom solutions to the service provider and corporate enterprise markets through professional services and cloud platforms, today announced financial results for the fourth quarter and full-year 2013.
Sign-up for InterCloud Systems Reports Fourth Quarter and Full Year 2013 Results investment picks
SAN JOSE, Calif., May 20, 2014 (GLOBE NEWSWIRE) -- Ubiquiti Networks, Inc. (Nasdaq:UBNT) , a next-generation communications technology company, today announced that the InterContinental Bali Resort has selected Ubiquiti products to provide superior wireless Internet access to guests across its 44-acre complex.
Sign-up for InterContinental Bali Resort Selects Ubiquiti to Support Wireless Connectivity for Its Five-Star Luxury Hotel investment picks
IntercontinentalExchange Group (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today a $0.65 per share dividend for the second quarter of 2014.
Sign-up for IntercontinentalExchange Declares Quarterly Dividend of $0.65 Per Share investment picks
WILMINGTON, Del., April 7, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, today announced that its patent holding subsidiaries have entered into a worldwide, non-exclusive, royalty bearing patent license agreement with Fujitsu Limited ("Fujitsu"). The agreement covers the sale of Fujitsu's 2G, 3G and 4G terminal unit and infrastructure equipment products, including LTE and LTE-Advanced products.
Sign-up for InterDigital and Fujitsu Limited Agree to Worldwide Patent License Agreement investment picks
WILMINGTON, Del., April 18, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, today announced that the company will release its first quarter 2014 financial results before market open on Thursday, May 1, 2014.
Sign-up for InterDigital Announces Date for First Quarter 2014 Financial Results investment picks
WILMINGTON, Del., May 21, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, today announced that the company's executives will present at two technology investment conferences in New York.
Sign-up for InterDigital Executives to Present at Cowen, Stephens Investment Conferences investment picks
WILMINGTON, Del., May 19, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, today announced that an experienced government relations professional, Robert Stien, is joining the company in the newly created position of Vice President, Government Relations and Regulatory Affairs.
Sign-up for InterDigital Introduces New Vice President of Government Relations and Regulatory Affairs investment picks
WILMINGTON, Del., May 21, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, today announced that it expects its total second quarter 2014 revenue to be between $65 million and $72 million.
Sign-up for InterDigital Issues Revenue Guidance for Second Quarter 2014 investment picks
WILMINGTON, Del., May 21, 2014 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq:IDCC) , a wireless research and development company, announced today that it will webcast its 2014 Annual Meeting of Shareholders on Thursday, June 12, 2014 at 11:00 a.m. Eastern Time.
Sign-up for InterDigital to Webcast Annual Meeting of Shareholders on June 12, 2014 investment picks
ATLANTA , April 23, 2014 /PRNewswire/ -- Interface, Inc. (Nasdaq: TILE) , a worldwide carpet tile company and global leader in sustainability, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.03 per share, payable May 23, 2014 to shareholders of record as of May 9, 2014 .
Sign-up for Interface Declares Regular Quarterly Dividend investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: IntelliCell BioSciences Announces Positive Final Ruling Against Ironridge Global IV, LTD., and TCA Global Credit Master Fund, LP to Interface Declares Regular Quarterly Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry